Kantar Health Research Shows Patients 18-49 Have Much Worse Health Outcomes Than Older Patients; February Is American Heart Month
NEW YORK, February 1, 2012—Mental quality of life (QoL) is much lower among patients aged 18-49 who have experienced acute coronary syndrome (ACS) compared with patients who are 50 or older, according to research from Kantar Health’s National Health and Wellness Survey. ACS is defined as having experienced a heart attack or being diagnosed with unstable angina.
“Nearly 6.2 million Americans experience ACS, and while patients 18-49 years old make up a small part of this group they are showing much worse health outcomes compared with both older ACS patients and the general population their age,” says Michael Fronstin, COO of Kantar Health. “While physical QoL is the same across all ages, it’s concerning that mental QoL is significantly lower among these younger patients.”
Younger ACS patients have much higher work productivity loss compared with people their age without ACS – 43% lost productivity versus 16%. They also have significantly higher utilization of healthcare resources. ACS patients in the 18-49 age group have made 9.2 visits to their healthcare provider in the past six months (compared with 3.1 for non-ACS patients), and 42% have visited the emergency room in the past six months (compared with 12% among non-ACS patients).
“It’s important for people with the risk factors of heart disease to discuss with their physicians possible preventive steps to minimize their risk,” Mr. Fronstin says.
February is American Heart Month. Visit Kantar Health’s website to download more information on the burden of heart disease in the United States.
About the National Health and Wellness Survey (NHWS)
The study’s results were drawn from the 2010 US NHWS, a nationally representative, self-administered survey conducted annually via the Internet. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.
Kantar Health conducts NHWS annually in the US, Europe, Asia, Russia and Latin America. The survey is the largest self-reported database in the healthcare industry.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at firstname.lastname@example.org or +1-484-442-1431.